Purdue Univ. researchers have identified an important enzyme pathway that helps prevent new cells from receiving too many or too few chromosomes, a condition that has been directly linked to cancer and other diseases. The team found that near the end of cell division, the enzyme Cdc14 activates Yen1, an enzyme that ensures any breaks in DNA are fully repaired before the parent cell distributes copies of the genome to daughter cells.
It's a familiar trope in science fiction: In enemy territory, activate your cloaking device. And...
Our DNA is under constant attack from many sources. Fortunately, cells have several major DNA...
A drug under clinical trials to treat tuberculosis could be the basis for a class of broad-spectrum drugs that act against various bacteria, fungal infections and parasites, yet evade resistance, according to a study by Univ. of Illinois chemists and collaborators. The team determined the different ways the drug SQ109 attacks the tuberculosis bacterium and how the drug can be tweaked to target other pathogens from yeast to malaria.
A novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers says. The team of researchers developed the drug and tested it in animals infected with a virus closely related to one that causes the measles. As reported, virus levels were significantly reduced when infected animals received the drug by mouth.
In the midst of the diabetes epidemic, a glimmer of good news: Heart attacks, strokes and other complications from the disease are plummeting. Over the last two decades, the rates of heart attacks and strokes among diabetics fell by more than 60%, a new federal study shows. The research also confirms earlier reports of drastic declines in diabetes-related kidney failure and amputations.
In a new study, researchers from North Carolina State Univ., UNC-Chapel Hill and other institutions have taken the first steps toward creating a roadmap that may help scientists narrow down the genetic cause of numerous diseases. Their work also sheds new light on how heredity and environment can affect gene expression.
T-cells use a complex process to recognize foreign pathogens and diseased cells. In a paper published in Cell, researchers add a new level of understanding to that process by describing how the T-cell receptors use mechanical contact—the forces involved in their binding to the antigens—to make decisions about whether or not the cells they encounter are threats.
Researchers have discovered that the so-called HOPE method allows tissue samples to be treated such that they do not only meet the requirements of clinical histology, but can still be characterized later on by modern methods of proteomics, a technique that analyzes all proteins at once. This differs from the traditional formalin-based approach that cross-links protein molecules.
The next time you feel a sneeze coming on, raise your elbow to cover up that multiphase turbulent buoyant cloud you’re about to expel. That’s right: A novel study by Massachusetts Institute of Technology researchers shows that coughs and sneezes have associated gas clouds that keep their potentially infectious droplets aloft over much greater distances than previously realized.
Chances are you've heard of mapping genes to diagnose rare diseases, predict your risk of cancer and tell your ancestry. But to uncover food poisonings? The nation's disease detectives are beginning a program to try to outsmart outbreaks by routinely decoding the DNA of potentially deadly bacteria and viruses.
Using magnetically controlled nanoparticles to force tumor cells to "self-destruct" sounds like science fiction, but could be a future part of cancer treatment, according to new research.
Scientists have created a detailed, three-dimensional wiring diagram of the mouse brain. That should help researchers seek clues about how the human brain works in health and disease.
Chemotherapeutic drugs excel at fighting cancer, but they're not so efficient at getting where they need to go. Now, researchers are developing a better delivery method by encapsulating the drugs in nanoballoons – which are tiny modified liposomes that, upon being struck by a red laser, pop open and deliver concentrated doses of medicine.
Novartis said it's cutting off late-stage research into a potential chronic heart failure treatment because the drug has proven so effective, sending shares to an all-time high when markets opened Monday. Patients taking its twice-daily pill labeled LCZ696 lived longer without being hospitalized for heart failure than those who received a standard of care, Novartis said.
New research is boosting hopes that weight-loss surgery can put some patients' diabetes into remission for years and perhaps in some cases, for good. Doctors on Monday gave longer results from a landmark study showing that stomach-reducing operations are better than medications for treating "diabesity," the deadly duo of obesity and Type 2 diabetes.
A new study gives a big boost to fixing a bad aortic valve, the heart's main gate, without open-heart surgery. Survival rates were better one year later for people who had a new valve placed through a tube into an artery instead. The results were reported at an American College of Cardiology conference in Washington and prompted some doctors to predict that in the near future, far fewer people will be having the traditional operation.
What's good for the heart? Marriage, researchers say. A study of more than 3.5 million Americans finds that married people are less likely than singles, divorced or widowed folks to suffer any type of heart or blood vessel problem. This was true at any age, for women as well as for men, and regardless of other heart disease risk factors they had such as high cholesterol or diabetes.
A new understanding of proteins at the nexus of a cell’s decision to survive or die has implications for researchers who study cancer and age-related diseases, according to biophysicists at the Rice Univ.-based Center for Theoretical Biological Physics. Experiments and computer analysis of two key proteins revealed a previously unknown binding interface that could be addressed by medication.
A small study that examined brains from children who died found abnormal patterns of cell growth in autistic children. The research bolsters evidence that something before birth might cause autism, at least in some cases. Clusters of disorganized brain cells were discovered in tissue samples from brain regions important for regulating social functioning, emotions and communication, which can all be troublesome for children with autism.
Doctors commonly use MRI to diagnose tumors, damage from stroke and many other medical conditions. Neuroscientists also rely on it as a research tool for identifying parts of the brain that carry out different cognitive functions. Now, a team of biological engineers at Massachusetts Institute of Technology is trying to adapt MRI to a much smaller scale.
Women with a faulty breast cancer gene might face a greater chance of rare but deadly uterine tumors despite having their ovaries removed to lower their main cancer risks, doctors are reporting. A study of nearly 300 women with bad BRCA1 genes found four cases of aggressive uterine cancers years after they had preventive surgery to remove their ovaries. That rate is 26 times greater than expected.
The delicate balance between development of normal tissue and tumors depends in part upon a key molecular switch within cells, Yale School of Medicine researchers report in Science. Their findings reveal a potential mechanism used by cancer cells to recruit healthy cells to promote tumor growth and suggest new strategies to generate healthy tissue.
A multinational research team led by Duke Medicine scientists has identified a subclass of antibodies associated with an effective immune response to an HIV vaccine. The finding helps explain why a combination of two vaccines was able to show some effect, when one vaccine alone did not. The study also provides key insights that could aid development of new vaccines.
IBM is teaming up with the New York Genome Center to help fight brain cancer. The company said Wednesday that its Watson cloud computing system will be used in partnership with a New York-based genetic research center to help develop treatments for glioblastoma, the most common type of brain cancer in U.S. adults.
Small protein fragments, also called peptides, are promising as drugs because they can be designed for very specific functions inside living cells. Insulin and the HIV drug Fuzeon are some of the earliest successful examples, and peptide drugs are expected to become a $25 billion market by 2018. However, a major bottleneck has prevented peptide drugs from reaching their full potential.
Duke Univ. engineers have devised a way to improve the efficiency of lithotripsy—the demolition of kidney stones using focused shock waves. After decades of research, all it took was cutting a groove near the perimeter of the shock wave-focusing lens and changing its curvature.
Univ. of Michigan researchers have learned how to fix a cellular structure called the Golgi that mysteriously becomes fragmented in all Alzheimer's patients and appears to be a major cause of the disease. They say that understanding this mechanism helps decode amyloid plaque formation in the brains of Alzheimer's patients, plaques that kills cells and contributes to memory loss and other Alzheimer's symptoms.
- Page 1